BENODIAZEPINE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS
    5.
    发明授权
    BENODIAZEPINE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS 有权
    BENODIAZEPINE SPIROHYDANTOIN CGRP受体拮抗剂

    公开(公告)号:EP1606286B1

    公开(公告)日:2011-05-11

    申请号:EP04749375.4

    申请日:2004-03-10

    IPC分类号: C07D403/12 A61K31/55

    CPC分类号: C07D403/12 C07D235/02

    摘要: The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

    摘要翻译: 本发明涉及作为CGRP受体拮抗剂的化合物,其可用于治疗或预防其中涉及CGRP的疾病,例如头痛,偏头痛和丛集性头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的此类疾病中的用途。

    CGRP RECEPTOR ANTAGONISTS
    9.
    发明授权
    CGRP RECEPTOR ANTAGONISTS 有权
    CGRP受体拮抗剂

    公开(公告)号:EP1615914B1

    公开(公告)日:2010-05-05

    申请号:EP04750028.5

    申请日:2004-04-09

    CPC分类号: C07D401/14 C07D413/14

    摘要: The present invention is directed to compounds of Formula I and Formula II: (where variables R1, R2, R3, R4, R6, A, B, G, J, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

    摘要翻译: 本发明涉及用作CGRP拮抗剂的式I和式II化合物(其中变量R 1,R 2,R 3,R 4,R 6,A,B,G,J,W,X和Y如本文所定义) 受体,并可用于治疗或预防与CGRP有关的疾病,例如头痛,偏头痛和丛集性头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的此类疾病中的用途。